Rumi Scientific Announces Partnership with X‑Chem for Development of Lead Candidate in Huntington’s Disease
NEW YORK, Dec. 05, 2023 (GLOBE NEWSWIRE) — Rumi Scientific (“Rumi”), a developer of therapies for rare and neurodegenerative diseases...
Structural insight into allosteric modulation of protease-activated receptor 2
Novel irreversible covalent BTK inhibitors discovered using DNA-encoded chemistry
X‑Chem Announces Licensing of Second Drug Discovery Program to Otsuka
Waltham, Mass – January 4, 2020 – X-Chem Inc. (X-Chem), the global leader in DNA-Encoded Library (DEL) technology to identify novel drug leads, announced today that Otsuka Pharmaceutical Co., Ltd. (Otsuka) has licensed a second drug discovery program from X-Chem.
X‑Chem Announces Licensing of a Drug Discovery Program to Otsuka
Waltham, Mass – May 20, 2020 – X-Chem, Inc. (X-Chem), a privately held biotechnology company focused on applying its next-generation, industry-leading DNA-Encoded library (DEXTM) drug discovery platform to the generation of novel small molecule therapeutics, announced today that Otsuka Pharmaceutical Co., Ltd. (Otsuka) has licensed a drug discovery program from X-Chem.